Consultation: Medicinal Cannabis Program Fees and Charges Review
While the consultation is open you can make a submission at our consultation hub.
When it closes, we review the submissions. After that the submissions and our decision will be available on the same page at the consultation hub.
About this consultation
On 24 December 2021 the Office of Drug Control (ODC)introduced a single licence model for cultivation, production and/or manufacture activities along with simpler permit processes and administrative reforms to reduce regulatory burden.
Following these changes, the existing Medicinal Cannabis Program cost model has been reviewed, including the level at which fees and charges are set. The review determined that some regulatory effort was not included in the existing fees and charges for the Medicinal Cannabis Program. These costs have been reflected in the new fees and charges set out in a Consultation Paper.
The Consultation Paper summarises the findings of the fees and charges review, including the proposed changes, and seeks feedback from stakeholders.
Make a submission to the Medicinal Cannabis Program Fees and Charges Review
Recent consultations can be found on our ODC consultations page.